EVH — Evolent Health, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1628908 ·
Last close
$5.88
Market Cap
$661.39M
52W High
$6.01
52W Low
$2.26
ADV30
2,527,378
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 496,246,000 | 83,774,000 | -10,599,000 | -26,632,000 | 1,878,847,000 | 142,028,000 | 1,482,454,000 |
| Dec 2025 | 468,719,000 | 97,253,000 | -20,440,000 | -429,131,000 | 1,899,236,000 | 151,856,000 | 1,484,042,000 |
| Sep 2025 | 479,533,000 | 99,774,000 | -1,433,000 | -20,864,000 | 2,453,459,000 | 116,650,000 | 1,611,226,000 |
| Jun 2025 | 444,328,000 | 100,385,000 | 2,035,000 | -19,897,000 | 2,461,532,000 | 150,995,000 | 1,565,527,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$38,843,000
Investing CF
$-91,545,000
Financing CF
$-35,924,000
CapEx
$-34,088,000
Dividends Paid
$-11,127,000
Buybacks
$0
EPS Diluted TTM
$-5.15
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,315,327,000
Inventory
—
Receivables
$309,861,000
ST Investments
—
EBIT TTM
$-476,011,000
Pretax Income TTM
$-534,636,000
Interest Exp TTM
$58,625,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,888,825,984
EBITDA
$74,355,000
Free Cash Flow
$52,930,624
Enterprise Value
$1,476,665,344
Total Cash
$142,028,000
Total Debt
$985,425,024
Shares Out
112,481,067
Trailing EPS
$-4.68
Book Value
$3.52
ROE
-65.1%
ROA
-0.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,876,229,000 | -19,834,000 | -534,510,000 | 1,899,236,000 | 1,484,042,000 | — | 38,843,000 |
| Dec 2024 | 2,554,741,000 | -14,067,000 | -61,623,000 | 2,544,411,000 | 1,543,152,000 | — | 18,765,000 |
| Dec 2023 | 1,963,896,000 | -21,055,000 | -113,040,000 | 2,680,308,000 | 1,612,607,000 | — | 142,582,000 |
| Dec 2022 | 1,352,013,000 | -19,880,000 | -19,164,000 | 1,817,293,000 | 957,876,000 | — | -11,553,000 |
TTM Snapshot
Revenues TTM
$1,707,472,000
NetIncome TTM
$-59,378,000
OpCashFlow TTM
$0
Assets (Latest)
$2,544,411,000
Forward EPS
$0.38
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MUJ | BLACKROCK MUNIHOLDINGS NEW JERSEY QUALITY FUND, INC. | $657.90M | $12.37 | — |
| VMO | Invesco Municipal Opportunity Trust | $665.64M | $9.87 | — |
| GAIN | GLADSTONE INVESTMENT CORPORATION\DE | $655.47M | $16.46 | — |
| NMFC | New Mountain Finance Corp | $667.78M | $7.07 | — |
| ACP | abrdn Income Credit Strategies Fund | $654.96M | $5.22 | — |
News headlines (Yahoo Finance, 1h cache)
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
2026-07-08 20:30 · Yahoo
Should You Buy Evolent Health (EVH) After Golden Cross?
2026-07-03 13:55 · Yahoo
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
2026-06-29 14:52 · Yahoo
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks
2026-06-12 20:05 · Yahoo
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
2026-06-09 16:20 · Yahoo
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
2026-06-02 13:03 · Yahoo
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
2026-05-30 20:27 · Yahoo
3 Healthcare Stocks We Approach with Caution
2026-05-29 17:28 · Yahoo
3 Reasons EVH is Risky and 1 Stock to Buy Instead
2026-05-27 16:01 · Yahoo
3 Russell 2000 Stocks We’re Skeptical Of
2026-05-23 16:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.